4//SEC Filing
Cavalier Jason 4
Accession 0001193125-26-007760
CIK 0001327273other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:30 PM ET
Size
5.1 KB
Accession
0001193125-26-007760
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-06$3.36/sh−769$2,587→ 518,547 total
Footnotes (1)
- [F1]Shares were sold to cover taxes upon the vesting of restricted stock units ("RSUs") pursuant to a mandatory Rule 10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001883290
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:30 PM ET
- Size
- 5.1 KB